Treating iron overload in patients with non-transfusion-dependent thalassemia

Ali T. Taher, Vip Viprakasit, Khaled M. Musallam, M. Domenica Cappellini

Research output: Contribution to journalArticlepeer-review


Despite receiving no or only occasional blood transfusions, patients with non-transfusion-dependent thalassemia (NTDT) have increased intestinal iron absorption and can accumulate iron to levels comparable with transfusion-dependent patients. This iron accumulation occurs more slowly in NTDT patients compared to transfusion-dependent thalassemia patients, and complications do not arise until later in life. It remains crucial for these patients' health to monitor and appropriately treat their iron burden. Based on recent data, including a randomized clinical trial on iron chelation in NTDT, a simple iron chelation treatment algorithm is presented to assist physicians with monitoring iron burden and initiating chelation therapy in this group of patients.

Original languageEnglish
Pages (from-to)409-415
Number of pages7
JournalAmerican Journal of Hematology
Issue number5
Publication statusPublished - May 2013

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Treating iron overload in patients with non-transfusion-dependent thalassemia'. Together they form a unique fingerprint.

Cite this